Peter Young will be participating on a panel titled "Early Seed Financing: Funding Strategies to Prepare Start-Ups for Growth" on Wednesday, January 11th at the Biotech Showcase 2023 in San Francisco.
Biotech Showcase 2023
Pappas Capital Strengthens Team with Appointment of W. Richard Staub as Venture Partner
RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment will strengthen the Pappas Capital team in support of the firm's continued growth and expansion.
Biotech Showcase 2023
Elizabeth Kelly will be participating on a panel titled "Finance Trends in Asia Pacific" on Tuesday, January 10th at the Biotech Showcase 2023 in San Francisco.
NC Global Advantage Forum
Karent LeVert will be speaking at the NC Global Advantage Forum on the impact of climate change on agriculture and how North Carolina's growing AgTech prowess can make a global impact.
Life Sciences Summit
Peter Young will be participating on a panel titled "Investor and Partner Insights" on November 2nd at the virtual Life Sciences Summit.
The Future of the Life Sciences Industry in Wilmington, NC
Art Pappas will be participating on a panel titled "How does Wilmington ecosystem need to support startups and how to attract funding" at The Future of the Life Sciences Industry in Wilmington, NC, on November 10th.
Positive Topline Data Announced from Mirum’s LIVMARLI Phase 3 MARCH Study in Progressive Familial Intrahepatic Cholestasis (PFIC)
FOSTER CITY, CA--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced positive topline results from its pivotal Phase 3 MARCH study evaluating LIVMARLI® (maralixibat) oral solution in 93 patients with progressive familial intrahepatic cholestasis (PFIC) in a broad range of subtypes, age one to 17 years. The primary endpoint of improvement in pruritus severity in PFIC2 was statistically significant (p=0.0098).
“The advancement of new medications, particularly for rare diseases like PFIC, is incredibly important and provides hope to families who are in need of a treatment option that can effectively address itch, the most burdensome aspect of the disease”
The primary analysis was conducted in PFIC2 patients (n=31). The secondary analyses were evaluated in the All-PFIC cohort, which included PFIC2 as well as additional PFIC subtypes (n=64). The Full-Study population included All-PFIC as well as supplemental patients who had previously undergone surgery, had truncating mutations and other patients (n=93).
Aidoc expands cardiology solutions by bringing Us2.ai's echo AI into proprietary operating system
NEW YORK, Oct. 20, 2022 -- Aidoc, the leading provider of healthcare AI solutions, announced today a partnership with Us2.ai to bring its FDA-cleared and CE Marked AI algorithm to analyze and interpret echocardiograms (echo) into its proprietary aiOS™.
Within Aidoc's aiOS – a first-in-market operating system that can orchestrate multiple independent AI algorithms across the native workflows of various specialties – the Us2.ai algorithm can deliver a fully automated and standardized echo report to sonographers and cardiologists.
Women in Agribusiness Summit 2022
Karen LeVert will be participating on a panel titled "Ag Innovations" at the Women in Agribusiness Summit 2022 in Dallas, TX on September 28th.
Recipients of the 2022 WIA Demeter Award of Excellence Announced
Topsfield, Mass., (August 25, 2022) – Three exceptional women have been named recipients of the 2022 Women in Agribusiness (WIA) Demeter Award of Excellence – Diane Allemang of FMC Corporation, Kendall Jones of ProAg and Karen LeVert of Pappas Capital and Ag TechInventures. The trio will be recognized next month at the 11th annual Women in Agribusiness Summit, which will be held in Dallas, September 26-28, at the Hyatt Regency Dallas.
